Erodible vessel sealing device without chemical or biological degradation
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61B-017/00
A61L-026/00
A61L-017/10
A61L-017/06
A61K-009/00
A61B-017/03
A61B-017/08
A61L-031/04
A61L-031/14
A61F-002/06
A61B-017/064
출원번호
US-0513688
(2003-04-24)
등록번호
US-8802124
(2014-08-12)
국제출원번호
PCT/SE03/00656
(2003-04-24)
§371/§102 date
20050103
(20050103)
국제공개번호
WO03/094740
(2003-11-20)
발명자
/ 주소
Tenerz, Lars
Åkerfeldt, Dan
Mathisen, Torbjörn
출원인 / 주소
Radi Medical Systems AB
대리인 / 주소
Foley & Lardner LLP
인용정보
피인용 횟수 :
0인용 특허 :
21
초록▼
The present invention provides a dissolvable medical sealing device (3, 4; 6, 7; 9) for closing a wound in vessel. A sealing device (3, 4, 6, 7, 9) according to the invention is made of a material that dissolves by means of physical processes, rather than by means of chemical or biological processes
The present invention provides a dissolvable medical sealing device (3, 4; 6, 7; 9) for closing a wound in vessel. A sealing device (3, 4, 6, 7, 9) according to the invention is made of a material that dissolves by means of physical processes, rather than by means of chemical or biological processes. Such a sealing device (3, 4; 6, 7; 9) can be made of polyethylene glycol, polypropylene glycol, copolymers containing ethylene glycol and propylene glycol, polyvinyl alcohol or polyvinyl pyrolidone, or any combinations thereof.
대표청구항▼
1. An implantable wound closure device for closing a wound in a vessel, comprising: a first sealing device configured to be positioned against an inner surface of a wall of the vessel, anda fastener fastened to the first sealing device, wherein the fastener is configured to pass through the wound an
1. An implantable wound closure device for closing a wound in a vessel, comprising: a first sealing device configured to be positioned against an inner surface of a wall of the vessel, anda fastener fastened to the first sealing device, wherein the fastener is configured to pass through the wound and to keep the first sealing device in place,wherein the first sealing device is made of a polymer material,wherein the first sealing device is configured to dissolve by erosion caused by physical processes occurring within the vessel without chemical or biological degradation,wherein, upon implantation, the first sealing device is configured to dissolve by erosion caused by the physical processes occurring within the vessel at at least one exposed surface of the first sealing device that is exposed to an interior of the vessel, andwherein the first sealing device consists of one or more of the following: polypropylene glycol, polyacrylic acid, polyvinyl methyl ether-maleic anhydride, xanthan gum, guar gum, and pectin. 2. An implantable wound closure device according to claim 1, further comprising a second sealing device made of a polymer material, adapted to be positioned against an outer surface of the wall of the vessel, and configured to dissolve by physical processes without substantial chemical or biological degradation. 3. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to dissolve in water by erosion caused by physical processes without substantial chemical or biological degradation. 4. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to start dissolving essentially immediately after positioning of the first sealing device within the vessel. 5. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to dissolve in seven days or less after the implantation. 6. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to dissolve in three days or less after the implantation. 7. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to dissolve in 24 hours after the implantation. 8. An implantable wound closure device according to claim 1, wherein the first sealing device is water-soluble. 9. An implantable wound closure device according to claim 1, wherein the first sealing device comprises polypropylene glycol. 10. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to erode due to blood flow wear on the first sealing device. 11. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to dissolve inside the vessel after three days and before seven days. 12. An implantable wound closure device according to claim 1, wherein the first sealing device is configured to dissolve inside the vessel in less than seven days. 13. An implantable wound closure device according to claim 1, wherein the first sealing device and the fastener are made from different materials. 14. An implantable wound closure device according to claim 1, wherein the fastener is configured to dissolve later than the first sealing device after the first sealing device is implanted in the vessel. 15. An implantable wound closure device for closing a wound in a vessel, comprising: a first sealing device configured to be positioned against an inner surface of a wall of the vessel, anda fastener fastened to the first sealing device, wherein the fastener is configured to pass through the wound and to keep the first sealing device in place,wherein the first sealing device is made of a polymer material,wherein the first sealing device is configured to dissolve by erosion caused by physical processes occurring within the vessel without chemical or biological degradation,wherein, upon implantation, the first sealing device is configured to dissolve by erosion caused by the physical processes occurring within the vessel at at least one exposed surface of the first sealing device that is exposed to an interior of the vessel, andwherein the first sealing device comprises at least 90% by weight of one or more of the following: polypropylene glycol, polyacrylic acid, polyvinyl methyl ether-maleic anhydride, xanthan gum, guar gum, and pectin. 16. An implantable wound closure device according to claim 15, further comprising a second sealing device made from a polymer material, adapted to be positioned against an outer surface of the wall of the vessel, and configured to dissolve by physical processes without substantial chemical or biological degradation. 17. An implantable wound closure device according to claim 15, wherein the first sealing device is configured to dissolve in water by erosion caused by physical processes without substantial chemical or biological degradation. 18. An implantable wound closure device according to claim 15, wherein the first sealing device is configured to start dissolving essentially immediately after positioning of the first sealing device within the vessel. 19. An implantable wound closure device according to claim 15, wherein the first sealing device is configured to dissolve in three days or less after the implantation. 20. An implantable wound closure device according to claim 15, wherein the first sealing device is configured to erode due to blood flow wear on the first sealing device. 21. An implantable wound closure device according to claim 15, wherein the first sealing device is configured to dissolve inside the vessel after three days and before seven days. 22. An implantable wound closure device according to claim 15, wherein the first sealing device is configured to dissolve inside the vessel in less than seven days.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (21)
Van Tassel, Robert A.; Hauser, Robert G., Barrier device for ostium of left atrial appendage.
Hermann George D. (Los Gatos CA) Mollenauer Kenneth H. (Santa Clara CA) Monfort Michelle Y. (Los Gatos CA) Ryan Timothy J. (Palo Alto CA) Tanaka Shigeru (Palo Alto CA), Laparoscopic tissue removal device.
Muth Ross R. (Brookfield CT) Totakura Nagabhushanam (Norwalk CT) D\Alessio Keith (Warsaw IN), Methods of forming bioabsorbable objects from polyvinyl alcohol.
Muijs Van de Moer Wouter M. (Grindweg 56 3055 VB Rotterdam NLX) Rienks Rienk (Mennestraat 17 3882 AN Putten NLX), Occlusion assembly for sealing openings in blood vessels and a method for sealing openings in blood vessels.
Erlebacher Jay (55 Woodland Park Dr. Tenafly NJ 07670) Goldweit Richard S. (82 Park St. Tenafly NJ 07670), Percutaneous arterial puncture seal device and insertion tool therefore.
Kensey Kenneth (Chester Springs PA) Nash John (Downingtown PA) Evans Douglas (King of Prussia PA), Plug device with pulley for sealing punctures in tissue and methods of use.
Kensey Kenneth (Chester Springs PA) Nash John E. (Downington PA) Evans Douglas (Devon PA), System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.